524 related articles for article (PubMed ID: 19886148)
21. Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England.
Russo EA; Harris AW; Campbell S; Lindsay J; Hart A; Arebi N; Milestone A; Tsai HH; Walters J; Carpani M; Westaby D; Thillainayagam A; Bansi D; Ghosh S
Aliment Pharmacol Ther; 2009 Feb; 29(3):308-14. PubMed ID: 19035973
[TBL] [Abstract][Full Text] [Related]
22. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
Ott C; Obermeier F; Thieler S; Kemptner D; Bauer A; Schölmerich J; Rogler G; Timmer A
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
[TBL] [Abstract][Full Text] [Related]
23. Accelerated infliximab infusions are safe and well tolerated in patients with inflammatory bowel disease.
Clare DF; Alexander FC; Mike S; Dan G; Allan F; Lisa W; Peter HJ
Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):71-5. PubMed ID: 19060632
[TBL] [Abstract][Full Text] [Related]
24. Infliximab drug and infusion costs among patients with Crohn's disease in a commercially-insured setting.
Ollendorf DA; Lidsky L
Am J Ther; 2006; 13(6):502-6. PubMed ID: 17122530
[TBL] [Abstract][Full Text] [Related]
25. Preoperative infliximab therapy does not increase morbidity and mortality after laparoscopic resection for inflammatory bowel disease.
Krane MK; Allaix ME; Zoccali M; Umanskiy K; Rubin MA; Villa A; Hurst RD; Fichera A
Dis Colon Rectum; 2013 Apr; 56(4):449-57. PubMed ID: 23478612
[TBL] [Abstract][Full Text] [Related]
26. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
Jakobovits SL; Jewell DP; Travis SP
Aliment Pharmacol Ther; 2007 May; 25(9):1055-60. PubMed ID: 17439506
[TBL] [Abstract][Full Text] [Related]
27. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease.
Ananthakrishnan AN; McGinley EL; Binion DG
Gut; 2008 Feb; 57(2):205-10. PubMed ID: 17905821
[TBL] [Abstract][Full Text] [Related]
28. Impact of persistence with infliximab on hospitalizations in ulcerative colitis.
Carter CT; Leher H; Smith P; Smith DB; Waters HC
Am J Manag Care; 2011 Jun; 17(6):385-92. PubMed ID: 21756009
[TBL] [Abstract][Full Text] [Related]
29. Diverticulitis in California from 1995 to 2006: increased rates of treatment for younger patients.
Etzioni DA; Cannom RR; Ault GT; Beart RW; Kaiser AM
Am Surg; 2009 Oct; 75(10):981-5. PubMed ID: 19886149
[TBL] [Abstract][Full Text] [Related]
30. Risk of arterial thrombotic events in inflammatory bowel disease.
Ha C; Magowan S; Accortt NA; Chen J; Stone CD
Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
[TBL] [Abstract][Full Text] [Related]
31. Surgical and nonsurgical hospitalization rates and charges for patients with ulcerative colitis in Italy: a 10-year cohort study.
Kohn A; Fano V; Monterubbianesi R; Davoli M; Marrollo M; Stasi E; Perucci C; Prantera C
Dig Liver Dis; 2012 May; 44(5):369-74. PubMed ID: 22197692
[TBL] [Abstract][Full Text] [Related]
32. Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.
Horton N; Wu X; Philpott J; Garber A; Achkar JP; Brzezinski A; Lashner BA; Shen B
Dig Dis Sci; 2016 Nov; 61(11):3270-3277. PubMed ID: 27619393
[TBL] [Abstract][Full Text] [Related]
33. Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study.
Murthy SK; Begum J; Benchimol EI; Bernstein CN; Kaplan GG; McCurdy JD; Singh H; Targownik L; Taljaard M
Gut; 2020 Feb; 69(2):274-282. PubMed ID: 31196874
[TBL] [Abstract][Full Text] [Related]
34. Infliximab in ulcerative colitis: the impact of preoperative treatment on rates of colectomy and prescribing practices in the province of British Columbia, Canada.
Moore SE; McGrail KM; Peterson S; Raval MJ; Karimuddin AA; Phang PT; Bressler B; Brown CJ
Dis Colon Rectum; 2014 Jan; 57(1):83-90. PubMed ID: 24316950
[TBL] [Abstract][Full Text] [Related]
35. Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?
Rutgeerts P; Vermeire S; Van Assche G
Gut; 2007 Apr; 56(4):453-5. PubMed ID: 17369375
[TBL] [Abstract][Full Text] [Related]
36. [Infliximab--practical guidelines for the treatment of Crohn's disease].
Bauerfeind P; Beglinger C; Beltinger J; Braegger C; Eigenmann F; Fried M; Guyot J; Hürlimann R; Michetti P; Seibold F; Straumann A
Rev Med Suisse; 2006 Jul; 2(74):1807-15. PubMed ID: 16927560
[TBL] [Abstract][Full Text] [Related]
37. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
Yamamoto-Furusho JK; Uzcanga LF
Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
[TBL] [Abstract][Full Text] [Related]
38. Treatment with biologic therapies and the risk of cancer in patients with IBD.
Biancone L; Calabrese E; Petruzziello C; Pallone F
Nat Clin Pract Gastroenterol Hepatol; 2007 Feb; 4(2):78-91. PubMed ID: 17268543
[TBL] [Abstract][Full Text] [Related]
39. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation.
Odes S; Vardi H; Friger M; Wolters F; Russel MG; Riis L; Munkholm P; Politi P; Tsianos E; Clofent J; Vermeire S; Monteiro E; Mouzas I; Fornaciari G; Sijbrandij J; Limonard C; Van Zeijl G; O'morain C; Moum B; Vatn M; Stockbrugger R;
Gastroenterology; 2006 Sep; 131(3):719-28. PubMed ID: 16952541
[TBL] [Abstract][Full Text] [Related]
40. Repeat endoscopy affects patient management in pediatric inflammatory bowel disease.
Thakkar K; Lucia CJ; Ferry GD; McDuffie A; Watson K; Tsou M; Gilger MA
Am J Gastroenterol; 2009 Mar; 104(3):722-7. PubMed ID: 19209163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
